Highly Anticipated FDA Decision Comes Just in Time for Back-to-School Season
Posted
Frank Vinluan (via MedCity News)
FDA approval of neffy, a nasal spray formulation of epinephrine, clears the way for ARS Pharma to launch the product in time for the new school year. In other recent regulatory news, the FDA approved updated Covid-19 vaccines as well as a new mpox vaccine.
The post Highly Anticipated FDA Decision Comes Just in Time for Back-to-School Season appeared first on MedCity News.
